Lineage-defined leiomyosarcoma subtypes emerge years before diagnosis and determine patient survival
Nathaniel D. Anderson(Wellcome Sanger Institute), Adam Shlien, Moritz Gerstung(European Bioinformatics Institute), Huayun Hou(Hospital for Sick Children), Matthew Zatzman(University of Toronto), Fabio Fuligni(Hospital for Sick Children), Marcus Q. Bernardini(University Health Network), Marjan Rouzbahman(University Health Network), Carol J. Swallow(Princess Margaret Cancer Centre), Sheena Guram(Mount Sinai Hospital), Rebecca A. Gladdy(Lunenfeld-Tanenbaum Research Institute), Peter C. Ferguson(Mount Sinai Hospital), James J. Dowling(University of Toronto), Rima Al‐awar(Ontario Institute for Cancer Research), Kyoko E. Yuki(McGill University), Federico Comitani(Hospital for Sick Children), Irene L. Andrulis(University of New Brunswick), Nicholas Light(University of Toronto), Yael Babichev(Mount Sinai Hospital), Daniel Durocher(Mount Sinai Hospital), Brendan C. Dickson(Mount Sinai Hospital), Claire Wunker(Mount Sinai Hospital), Ludmil B. Alexandrov(UC San Diego Health System), Stefan C. Dentro(The Francis Crick Institute), Anant Maheshwari(Hospital for Sick Children), John Thompson(Hospital for Sick Children), Mehdi Layeghifard(Hospital for Sick Children), Albiruni R. Abdul Razak(Mount Sinai Hospital), Rosemarie E. Venier(University of Toronto), Richard Marcellus(Ontario Institute for Cancer Research), Jay S. Wunder(Mount Sinai Hospital)
Cited by 64
Related Papers
Signatures of mutational processes in human cancer
|Nature|2013|10.1k
Genomic Classification and Prognosis in Acute Myeloid Leukemia
|New England Journal of Medicine|2016|4.4k